ArticlePloS one2025

3-O-acetylrubiarbonol B preferentially targets EGFR and MET over rubiarbonol B to inhibit NSCLC cell growth.

A-Young Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.